Clincosm LogoSign in Get a demo

parainfluenza

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)

Recruiting
  • Lower Respiratory Tract Infection
  • +3 more
  • Duarte, California
  • +59 more
Jun 3, 2022

Parainfluenza Trial in United States (DAS181 dry powder, formulation F02, Lactose Placebo)

Completed
  • Parainfluenza
  • DAS181 dry powder, formulation F02
  • Lactose Placebo
  • Phoenix, Arizona
  • +44 more
Sep 21, 2017

Parainfluenza Trial in United States (DAS181-F02 Dry Powder in Bulk, DAS181-F02 Nebulized Formulation Inhaled Dose)

Completed
  • Parainfluenza
  • DAS181-F02 Dry Powder in Bulk
  • DAS181-F02 Nebulized Formulation Inhaled Dose
  • Duarte, California
  • +22 more
Jul 18, 2017

Specific Respiratory Infections as Triggers of Acute Medical

Completed
  • Influenza, Human
  • +6 more
    • London, United Kingdom
      University College London (UCL)
    May 3, 2017

    Parainfluenza, Virus Diseases Trial in Baltimore (rHPIV1 84/del170/942A, Lot PIV1 #104A vaccine, Placebo)

    Completed
    • Parainfluenza
    • Virus Diseases
    • rHPIV1 84/del170/942A, Lot PIV1 #104A vaccine
    • Placebo
    • Baltimore, Maryland
      Center for Immunization Research (CIR), Johns Hopkins Bloomberg
    Feb 22, 2013